Evidence map›Paper›PMID 35318736›Full record

ArticleImmunology and cell biology2022

Pseudomonas aeruginosa modulates neutrophil granule exocytosis in an in vitro model of airway infection.

Daniel R Laucirica, Craig J Schofield, Samantha A McLean, Camilla Margaroli, Patricia Agudelo-Romero, Stephen M Stick, Rabindra Tirouvanziam, Anthony Kicic, Luke W Garratt, Western Australian Epithelial Research Program (WAERP) and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Immunology and cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Differential Regulation of Granule Release in Platelets and Immune Cells.TH open : companion journal to thrombosis and haemostasis · 2026
    Article
  4. Wound repair and immune function in theFrontiers in cellular and infection microbiology · 2025
    Review
  5. Article
  6. A Noble Extract ofMicroorganisms · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Daniel R LauciricaFaculty of Health and Medical Sciences, University of Western Australia, Nedlands, WA, Australia.ORCID 0000-0002-2208-0844
Craig J SchofieldWal-Yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.ORCID 0000-0001-9771-3194
Samantha A McLeanWal-Yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.ORCID 0000-0002-0189-534X
Camilla MargaroliDepartment of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-3952-0778
Patricia Agudelo-RomeroWal-Yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.ORCID 0000-0002-3703-4111
Stephen M StickFaculty of Health and Medical Sciences, University of Western Australia, Nedlands, WA, Australia.ORCID 0000-0002-5386-8482
Rabindra TirouvanziamDepartment of Pediatrics, Emory University, Atlanta, GA, USA.ORCID 0000-0003-3526-9985
Anthony KicicFaculty of Health and Medical Sciences, University of Western Australia, Nedlands, WA, Australia.ORCID 0000-0002-0008-9733
Luke W GarrattWal-Yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.ORCID 0000-0001-9381-326X
Western Australian Epithelial Research Program (WAERP)Wal-Yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
Australian Respiratory Early Surveillance Team for CF (AREST CF)Wal-Yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
The Kids Research Institute Australia · AUEmory University · USUniversity of Alabama at Birmingham · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A population of neutrophils recruited into cystic fibrosis (CF) airways is associated with proteolytic lung damage, exhibiting high expression of primary granule exocytosis marker CD63 and reduced phagocytic receptor CD16. Causative factors for this population are unknown, limiting intervention. Here we present a laboratory model to characterize responses of differentiated airway epithelium and neutrophils following respiratory infection. Pediatric primary airway epithelial cells were cultured at the air-liquid interface, challenged individually or in combination with rhinovirus (RV) and Pseudomonas aeruginosa, then apically washed with medical saline to sample epithelial infection milieus. Cytokine multiplex analysis revealed epithelial antiviral signals, including IP-10 and RANTES, increased with exclusive RV infection but were diminished if P. aeruginosa was also present. Proinflammatory signals interleukin-1α and β were dominant in P. aeruginosa infection milieus. Infection washes were also applied to a published model of neutrophil transmigration into the airways. Neutrophils migrating into bacterial and viral-bacterial co-infection milieus exhibited the in vivo CF phenotype of increased CD63 expression and reduced CD16 expression, while neutrophils migrating into milieus of RV-infected or uninfected cultures did not. Individually, bacterial products lipopolysaccharide and N-formylmethionyl-leucyl-phenylalanine and isolated cytokine signals only partially activated this phenotype, suggesting that additional soluble factors in the infection microenvironment trigger primary granule release. Findings identify P. aeruginosa as a trigger of acute airway inflammation and neutrophil primary granule exocytosis, underscoring potential roles of airway microbes in prompting this neutrophil subset. Further studies are required to characterize microbes implicated in primary granule release, and identify potential therapeutic targets.

Indexed as

Cystic FibrosisPseudomonas InfectionsCytokinesExocytosisHumansNeutrophilsPseudomonas aeruginosaCytokinesAirway epitheliumcystic fibrosisinnate immunityneutrophilsPseudomonasrhinovirus

Identifiers

PMID35318736
PMCPMC9544492
OpenAlexW4220704350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.